Skip to main content

Table 3 Association of selected biomarkers of glycaemic control, fat profile, and systemic inflammation with chronic respiratory symptoms (CRS)

From: Role of blood glucose and fat profile in lung function pattern of Indian type 2 diabetic subjects

 

Cough

N = 62 (7.17%)

Dyspnea

N = 197 (22.77%)

Allergy sym.

N = 112 (12.95)

Asthma/COPD

N = 26 (3.01%)

FPGa

1.01 (1.00–1.02)

1.01 (1.00–1.02)

1.00 (1.00–1.01)

1.00 (0.98–1.01)

2hPPGa

1.00 (1.00–1.01)

1.00 (1.00–1.01)

1.00 (0.99–1.00)

1.00 (0.99–1.01)

Hemoglobinb

1.05 (0.81–1.35)

0.96 (0.77–1.20)

0.92 (0.71–1.18)

1.03 (0.70–1.50)

HbA1ca

1.15 (0.94–1.41)

1.02 (0.87–1.19)

0.99 (0.81–1.19)

0.91 (0.69–1.20)

Cholesterolc

1.00 (0.99–1.01)

0.99 (0.98–1.00)

1.00 (0.99–1.02)

1.01 (0.99–1.02)

Triglyceridea

1.70 (0.76–3.83)

1.19 (0.65–2.17)

0.51 (0.25–1.17)

1.34 (0.47–3.84)

HDLd

0.98 (0.92–0.92)

0.98 (0.94–1.02)

1.04 (0.99–1.08)

1.04 (0.98–1.12)

WBCa

3.09 (0.51–18.92)

1.37 (0.37–5.12)

0.35 (0.06–1.96)

1.37 (0.12–16.10)

  1. FPG Fasting plasma glucose, 2hrsPPG 2 hrs. Post meal plasma glucose
  2. All variables are Odds Ratio (95% CI)
  3. aAdjusted for age, BMI, and smoking
  4. bAdjusted for age, gender BMI, and smoking
  5. cAdjusted for age, BMI, smoking, aspirin, and statin
  6. dAdjusted for age, gender, BMI, smoking, and aspirin
  7. Bold “OR” are significant at p < 0.05